Johnson & Johnson (NYSE: JNJ) shares ended yesterday’s trading session at a 52-week high, adding 9.5% since the April 14 publication of a robust quarterly report with results above Wall Street’s expectations. Earnings per share grew by 9.5% YoY to $2.30, revenue increased by 6.7% …
The coronavirus pandemic looks set to trigger the next economic recession, given the ongoing shutdowns in various industries around the world. A steep pullback in the stock market already provides clear insight that things are not well. The S&P 500 is already down by more …
Johnson & Johnson shares lost 6.2% in value at the end of last week, October 18, renewing the one-month low after reporting traces of asbestos in one of the batch of baby powder following an FDA random test. At the beginning of last week, the …
Johnson & Johnson Stock Continues to Fall After Asbestos Report (NYSE: JNJ) Read More »